Insiders · Profile

Skerlj Renato

Chief Scientific Officer at X4 Pharmaceuticals. Filing since 9 Sep 2020. CIK 0001814632

Company
Date
Role
Action
Shares
Amount
Of holding
9 Sep 2020
Chief Scientific Officer
Sold, plan not stated
5,834
$46.96K
12.2%
1 decision on file.